Style | Citing Format |
---|---|
MLA | Dayani L, et al.. "Immunomodulatory Effects of Cyclotides Isolated From Viola Odorata in an Experimental Autoimmune Encephalomyelitis Animal Model of Multiple Sclerosis." Multiple Sclerosis and Related Disorders, vol. 64, no. , 2022, pp. -. |
APA | Dayani L, Dinani MS, Aliomrani M, Hashempour H, Varshosaz J, Taheri A (2022). Immunomodulatory Effects of Cyclotides Isolated From Viola Odorata in an Experimental Autoimmune Encephalomyelitis Animal Model of Multiple Sclerosis. Multiple Sclerosis and Related Disorders, 64(), -. |
Chicago | Dayani L, Dinani MS, Aliomrani M, Hashempour H, Varshosaz J, Taheri A. "Immunomodulatory Effects of Cyclotides Isolated From Viola Odorata in an Experimental Autoimmune Encephalomyelitis Animal Model of Multiple Sclerosis." Multiple Sclerosis and Related Disorders 64, no. (2022): -. |
Harvard | Dayani L et al. (2022) 'Immunomodulatory Effects of Cyclotides Isolated From Viola Odorata in an Experimental Autoimmune Encephalomyelitis Animal Model of Multiple Sclerosis', Multiple Sclerosis and Related Disorders, 64(), pp. -. |
Vancouver | Dayani L, Dinani MS, Aliomrani M, Hashempour H, Varshosaz J, Taheri A. Immunomodulatory Effects of Cyclotides Isolated From Viola Odorata in an Experimental Autoimmune Encephalomyelitis Animal Model of Multiple Sclerosis. Multiple Sclerosis and Related Disorders. 2022;64():-. |
BibTex | @article{ author = {Dayani L and Dinani MS and Aliomrani M and Hashempour H and Varshosaz J and Taheri A}, title = {Immunomodulatory Effects of Cyclotides Isolated From Viola Odorata in an Experimental Autoimmune Encephalomyelitis Animal Model of Multiple Sclerosis}, journal = {Multiple Sclerosis and Related Disorders}, volume = {64}, number = {}, pages = {-}, year = {2022} } |
RIS | TY - JOUR AU - Dayani L AU - Dinani MS AU - Aliomrani M AU - Hashempour H AU - Varshosaz J AU - Taheri A TI - Immunomodulatory Effects of Cyclotides Isolated From Viola Odorata in an Experimental Autoimmune Encephalomyelitis Animal Model of Multiple Sclerosis JO - Multiple Sclerosis and Related Disorders VL - 64 IS - SP - EP - PY - 2022 ER - |